Spots Global Cancer Trial Database for Evaluation of Safety and Efficacy of Estetrol in Healthy Men
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of Safety and Efficacy of Estetrol in Healthy Men
Official Title: A Phase I, Double-blind, Randomised, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Multiple Dosages of Estetrol in Healthy Men
Study ID: NCT02718378
Conditions
Study Description
Brief Summary: The current study is designed as a phase Ib multiple dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of E4 in healthy men after daily oral administration for 28 days.
Detailed Description:
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: Yes
Locations
QPS Netherlands BV, Groningen, , Netherlands
Contact Details
Name: Tjeert Mensinga, MD, PhD
Affiliation: QPS Netherlands BV
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
